719
Panorama Actual del Medicamento
NUEVOS FÁRMACOS
MEDICAMENTOS DADOS DE baja (SEPTIEMBRE 2012)
Código
NOMBRE, PRESENTACIÓN Y LABORATORIO
FECHA
6719619
ST
ACECLOFENACO APOTEX EFG 100 MG 20 COMPRIMIDOS RECUBIERTOS (APOTEX ESPAÑA S.L.)............
8-2012
6719626
ST
ACECLOFENACO APOTEX EFG 100 MG 40 COMPRIMIDOS RECUBIERTOS (APOTEX ESPAÑA S.L.)............
8-2012
9998127
ACICLOVIR RANBAXY EFG 200 MG 25 COMPRIMIDOS (RANBAXY)......................................................................
7-2012
6282304
ACICLOVIR RANBAXY EFG 200 MG 500 COMPRIMIDOS (RANBAXY)....................................................................
7-2012
8699254
ACICLOVIR TOPICO RANBAXY EFG 5% CREMA 15 G (RANBAXY)........................................................................
7-2012
8693399
ACICLOVIR TOPICO RANBAXY EFG 5% CREMA 2 G (RANBAXY)..........................................................................
7-2012
7726739
ACOVIL 1.25 MG 28 COMPRIMIDOS (SANOFI AVENTIS S.A.)..................................................................................
8-2012
6250617
AMOXI GOBENS 250 MG 500 SOBRES (NORMON)...................................................................................................
8-2012
7584339
AMOXI GOBENS 250 MG/5 ML SUSP 120 ML (NORMON).........................................................................................
8-2012
7053682
AMOXI GOBENS 250 MG/5 ML SUSP 60ML (NORMON)............................................................................................
8-2012
6632185
ST
ANASTROZOL TARBIS EFG 1 MG 28 COMPRIMIDOS RECUBIERTOS (TARBIS FARMA, S.L.)..........................
8-2012
8274772
BOLIDOL CODEINA 500/30 MG 20 SOBRES (ITALFARMACO).................................................................................
8-2012
8073054
BOSPORON 4 MG 30 COMPRIMIDOS (TEDEC MEIJI FARMA).................................................................................
9-2012
7571537
BREMON 500 MG 14 COMPRIMIDOS (ESTEVE)........................................................................................................
8-2012
6707456
BREMON 500 MG 21 COMPRIMIDOS (ESTEVE)........................................................................................................
8-2012
6489802
BREMON 500 MG 500 COMPRIMIDOS (ESTEVE)......................................................................................................
8-2012
8088997
CIPROFLOXACINO MYLAN EFG 250 MG 10 COMPRIMIDOS RECUBIERTOS (MYLAN PHARMACEUTICALS.
8-2012
8122486
CIPROFLOXACINO MYLAN EFG 250 MG 20 COMPRIMIDOS RECUBIERTOS (MYLAN PHARMACEUTICALS.
8-2012
8088812
CIPROFLOXACINO MYLAN EFG 500 MG 10 COMPRIMIDOS RECUBIERTOS (MYLAN PHARMACEUTICALS.
8-2012
8118854
CIPROFLOXACINO MYLAN EFG 500 MG 20 COMPRIMIDOS RECUBIERTOS (MYLAN PHARMACEUTICALS.
8-2012
8088249
CIPROFLOXACINO MYLAN EFG 750 MG 10 COMPRIMIDOS RECUBIERTOS (MYLAN PHARMACEUTICALS.
8-2012
7398059
CIPROFLOXACINO WINTHROP EFG 500 MG 10 COMPRIMIDOS (SANOFI AVENTIS S.A.).................................
7-2012
8937509
CIPROFLOXACINO WINTHROP EFG 500 MG 20 COMPRIMIDOS (SANOFI AVENTIS S.A.).................................
7-2012
6181577
CIPROFLOXACINO WINTHROP EFG 500 MG 500 COMPRIMIDOS (SANOFI AVENTIS S.A.)..............................
7-2012
6600948
CITALOPRAM ARGENOL EFG 20 MG 14 COMPRIMIDOS RECUBIERTOS (TEVA PHARMA S.L.U.)..................
8-2012
6600771
CITALOPRAM ARGENOL EFG 20 MG 28 COMPRIMIDOS RECUBIERTOS (TEVA PHARMA S.L.U.)..................
8-2012
9680084
CLAVUMOX 125/31.25 MG SUSPENSION ORAL 120 ML (ALLEN FARMACEUTICA).............................................
8-2012
9670009
CLAVUMOX 250/62.5 MG 12 SOBRES (ALLEN FARMACEUTICA)...........................................................................
8-2012
9761264
CLAVUMOX 250/62.5 MG 24 SOBRES (ALLEN FARMACEUTICA)............................................................................
8-2012
6049341
CLAVUMOX 250/62.5 MG 500 SOBRES (ALLEN FARMACEUTICA).........................................................................
8-2012
9669942
CLAVUMOX 500/125 MG 12 SOBRES (ALLEN FARMACEUTICA).............................................................................
8-2012
